Department of Urology, Seoul National University Hospital, Seoul, Korea.
BJU Int. 2012 Jul;110(2 Pt 2):E28-33. doi: 10.1111/j.1464-410X.2011.10667.x. Epub 2011 Nov 15.
There has been some controversy about the gender differences in survival in patients with RCC. Korean women with RCC had a lower proportion of clear cell histology and a higher proportion of chromophobe histology. This histological difference might have driven the better survival rates in Korean women.
To assess whether there are gender-specific differences in the clinicopathological features and prognosis in a large cohort of Korean patients with renal cell carcinoma (RCC) compared with Western patients.
Medical records of 1616 patients clinically diagnosed with RCC who underwent partial or radical nephrectomy were analysed between January 1988 and July 2009. In all, 1508 patients diagnosed with RCC based on pathology reports were included for evaluation. The mean follow-up period was 73.1 months. The gender-specific differences in the clinicopathological features and survival rates were evaluated using the Kaplan-Meier method and Cox proportional hazards models.
Of the 1508 patients, 439 (29.1%) were women. Korean men had a higher proportion of clear cell histology (84.3% vs 72.0%, P < 0.001) and a lower percentage of chromophobe histology (5.2% vs 12.5%, P < 0.001) than Korean women. There were no gender-specific differences in pathological T stage, positive lymph nodes or distant metastases, or Fuhrman's nuclear grade (P > 0.05). For both cancer-specific and overall survival, Kaplan-Meier curves showed that women had a better survival rate than men (P = 0.039 and P = 0.015, respectively).
Korean women with RCC had significantly better survival rates than Korean men. Additionally, Korean women with RCC had a lower proportion of clear cell histology and a higher proportion of chromophobe histology. This histological difference might have driven the better survival rates in Korean women.
关于 RCC 患者生存中的性别差异存在一些争议。韩国女性 RCC 患者中透明细胞组织学比例较低,嗜铬细胞瘤组织学比例较高。这种组织学差异可能导致韩国女性的生存率更高。
评估在韩国人群中,与西方人群相比,大样本肾细胞癌(RCC)患者的临床病理特征和预后是否存在性别特异性差异。
分析了 1988 年 1 月至 2009 年 7 月期间 1616 例接受部分或根治性肾切除术的临床诊断为 RCC 的患者的病历。共纳入 1508 例基于病理报告诊断为 RCC 的患者进行评估。平均随访时间为 73.1 个月。使用 Kaplan-Meier 方法和 Cox 比例风险模型评估了性别特异性临床病理特征和生存率的差异。
在 1508 例患者中,439 例(29.1%)为女性。与韩国女性相比,韩国男性透明细胞组织学比例较高(84.3%比 72.0%,P<0.001),嗜铬细胞瘤组织学比例较低(5.2%比 12.5%,P<0.001)。病理 T 分期、阳性淋巴结或远处转移或 Fuhrman 核分级在性别之间无差异(P>0.05)。在癌症特异性和总体生存率方面,Kaplan-Meier 曲线显示女性的生存率高于男性(P=0.039 和 P=0.015)。
韩国女性 RCC 的生存率明显高于韩国男性。此外,韩国女性 RCC 中透明细胞组织学比例较低,嗜铬细胞瘤组织学比例较高。这种组织学差异可能导致韩国女性的生存率更高。